Uncategorized

Challenges posed by counterfeit drugs to the pharmaceutical industry have affected the market share and raised health concerns among health professionals, Legislators, and suppliers. Internet marketing plays a pivotal role in dominating fake drugs over genuine ones. In addition, at various levels of the supply chain processes, high prospects of putting in copy-products make them …

Serialization, track & trace and counterfeit drugs: a short overview Read More »

Cleaning Program under the Revised Propositions The proposed revisions to USP <795>, USP <797>, as well as proposed USP <800>, all include sections devoted to cleaning and surface sampling. Proposed/Revised USP <795> defines cleaning as: The process of removing soil (eg, organic and inorganic material) from objects and surfaces, normally accomplished by manually or mechanically …

Cleaning Program under the Revised Propositions Read More »

Compounding pharmacies come in many different shapes and sizes. They can consist of a pharmacist creating a drug under a doctor’s prescription or they can be pharmacy-type facilities that compound drugs and sell them like a manufacturer. Sporadic and serious infection outbreaks have been linked to compounding pharmacies outside of the hospital setting.1 These problems date …

Preventing Contamination In Compounding Facilities Read More »

The Food and Drug Administration (FDA or the Agency) is announcing the availability of a revised draft guidance entitled “Current Good Manufacturing Practice—Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act.” This revised draft guidance describes FDA’s policies regarding compounders registered under section 503B of the Federal Food, Drug, and …

Updated Guidance for Compounding Facilities 503B Read More »